Skip to main content
. 2023 May 22;13:1168942. doi: 10.3389/fonc.2023.1168942

Table 5.

Stratified analyses of the IRS2 polymorphisms on CRC risk.

SNP location Genotype Association results Tumor site Function Ref
OR (95% CI) P-Value
rs1805097G>A Exon GG 1.0 NR Colon An association of GA genotype with risk of CRC (32)
1.0 Rectal
GA 0.8 (0.6-0.9) Colon
1.0 (0.9-1.3) Rectal
AA 1.0 (0.7-1.3) Colon
0.9 (0.7-1.2) Rectal
GG 1.0 0.451 CRC No significant association with risk of CRC (36)
GA 1.15 (0.89–1.48)
AA 0.97 (0.68–1.38)
GG 1.0 NR CRC No significant association with risk of CRC (45)
GA 0.76 (0.48–1.19)
AA 1.11 (0.58–2.11)
GG 1.0 NR CRC No significant association with risk of CRC (41)
GA 1.04 (0.71–1.51) 0.854
AA 0.97 (0.56–1.66) 0.898
GG (M) 1.15 (0.90, 1.47)* 0.20 CRC No significant association with risk of CRC (21)
GG (F) 1.07 (0.82, 1.40) * 0.51
GA (M) 1.07 (0.84, 1.36) * 0.20
GA (F) 1.01 (0.77, 1.32) * 0.51
AA (M) 1.0 0.20
AA (F) 1.0 0.51
rs2289046A>G 3’UTR AA 1.0 NR CRC No significant association with risk of CRC (43)
AG 1.177(0.777–1.782) 0.441
GG 0.678 (0.334–1.374) 0.281
AA (M) 1.20 (0.93,1.55) 0.15 CRC No significant association with risk of CRC (21)
AA (F) 1.03 (0.78,1.34) * 0.57
AG (M) 1.13 (0.88, 1.46) * 0.15
AG (F) 0.94 (0.72, 1.23) * 0.57
GG (M) 1.0 0.15
GG (F) 1.0 0.57
rs754204C>T Intron CC (M) 1.0 0.14 CRC No significant association with risk of CRC (21)
CC (F) 1.0 0.78
TC (M) 1.08 (0.91, 1.30) * 0.14
TC (F) 0,98 (0.81, 1.20) * 0.78
TT (M) 1.17 (0.95, 1.45) * 0.14
TT (F) 1.04 (0.82, 1.31) * 0.78
rs4773082T>C _ TT (M) 1.0 0.27 CRC No significant association with risk of CRC (21)
TT (F) 1.0 0.81
CT (M) 1.11 (0.93, 1.33) * 0.27
CT (F) 1.00 (0.82,1.23) * 0.81
CC (M) 1.12 (0.89, 1.41) * 0.27
CC (F) 1.03 (0.80, 1.33) * 0.81

CRC, Colorectal cancer; M, Male; F, Female; NR, Not Reported.

*Hazard Ratio (HR); (-), Not Reported.